Tuesday December 18, 2018

Meditation Improves Mood, Sleep in Teenagers with Cancer

The mindfulness-based interventions for teenagers with cancer appear as a promising option to lighten psychological inconveniences of living with cancer

0
//
yoga, travel
In order to comprehend better the Indian seers constructed the special “BOAT” – named Yoga/Meditation. Pixabay
Republish
Reprint

Daily meditation can help improve mood and sleep in teenagers suffering or recuperating from cancer, a promising research shows.

Mindfulness-based meditation could lessen some symptoms associated with cancer in teenagers, according to the results of a clinical trial intervention led by researchers at University of Montreal and its affiliated CHU Sainte-Justine children’s hospital.

The process focuses on the present moment and the connection between the mind and body.

Adolescents living with cancer face not only the physical symptoms of their condition but also the anxiety and uncertainty related to the progression of the disease and the anticipation of physical and emotional pain related to illness and treatment.

meditation
Daily meditation can help improve mood and sleep in teenagers suffering or recuperating from cancer. Pixabay

The researchers asked 13 adolescents with cancer to complete questionnaires covering mood (positive and negative emotions, anxiety and depression), sleep and quality of life.
The group was divided in two. The first group of eight adolescents were offered eight mindfulness-based meditation sessions and the remaining five adolescents in the control group were put on a wait-list.

After the last meditation session, patients from both groups filled out the same questionnaires a second time.

Also Read: Daily Meditation may keep you attentive in old age

“We found that teenagers that participated in the mindfulness group had lower scores in depression after our eight sessions. Girls from the mindfulness group reported sleeping better. We also noticed that they developed mindfulness skills to a greater extent than boys during the sessions,” explained Catherine Malboeuf-Hurtubise from University of Montreal.

The mindfulness-based interventions for teenagers with cancer appear as a promising option to lighten psychological inconveniences of living with cancer, she added. (IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

New Drug to Give Hopes to Bone Marrow Cancer Patients

It reduced the risk of progression or death by more than 50 per cent in both groups

0
Cancer
Cancer Ribbon. Pixabay

A therapeutic drug has been found to improve outcomes and survival rates for patients with a serious type of bone marrow cancer.

In a clinical trial by researchers at Newcastle University in Britain, patients with newly diagnosed myeloma were treated with a drug called lenalidomide.

The results, published in the journal The Lancet Oncology, showed an improvement for those who received lenalidomide drug, compared to those not receiving it.

“This is a major breakthrough as it shows that the long-term use of lenalidomide significantly improves the time myeloma patients stay in remission after initial therapy,” said Professor Graham Jackson from the Northern Institute for Cancer Research at Newcastle.

Myeloma is a cancer of the plasma cells and it can affect several areas of the body, such as the spine, skull, pelvis and ribs. Current treatment usually involves chemotherapy and a stem-cell transplant.

cancer
New drug offers hope for bone marrow cancer patients. Pixabay

“It is a huge step and, importantly, identifies that for younger patients lenalidomide improves their overall survival for this difficult-to-treat bone marrow cancer,” Jackson said.

“Our research highlights that lenalidomide should be considered for newly diagnosed patients following stem-cell transplantation,” he added.

As part of the study, a total of 1,137 newly diagnosed patients were randomly assigned to lenalidomide maintenance therapy and 834 patients to observation – this was after they completed their initial treatment.

Also Read- Narendra Modi Accuses Congress of Aiding Those Who Want to Weaken Army

The results show that lenalidomide can prolong the average remission time by more than two years in younger patients and by well over a year in older, less fit patients.

It reduced the risk of progression or death by more than 50 per cent in both groups. (IANS)